摘要
目前,医疗保险对门诊特殊慢性病用药,主要在医疗机构药房配给,由医保经办机构定期与医疗机构结算,这在一定程度上减轻了参保人员的负担,但在用药便利性和经济性上还有所限制。为此,许多地方进行了门诊慢性病用药处方外配试点,取得了良好的社会效果。但处方外配的推广还存在诸多障碍和困难,需突破政策障碍,实现医保、医疗、医药信息联通共享,建立监管机制,使这项利民措施落到实处。
At present,the drugs for special chronic diseases in outpatient clinics are mainly distributed in pharmacies of medical institutions,which are settled regularly by medical insurance agencies and medical institutions. This reduces the burden of insured personnel to a certain extent,but there are still some restrictions on the convenience and economy of medication.Therefore,many places have carried out outpatient prescription dispensing pilot for chronic diseases,and achieved good social results.However,there are still many obstacles and difficulties in the promotion of prescription dispensing.It is necessary to break through the policy barriers,realize the sharing of medical insurance,medical and drugs,and establish a regulatory mechanism so as to put this pro-people measure into effect.
作者
侯仲华
Hou Zhonghua(Jiangxi Medical Insurance Research Association,Nanchang,330000)
出处
《中国医疗保险》
2019年第7期40-42,共3页
China Health Insurance
关键词
医疗保险
门诊慢性病
处方外配
政策建议
medical insurance
outpatient chronic diseases
prescription allocation
policy recommendations